Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Pfizer’s patents for Vyndaqel/Vyndamax are set to expire ... Recent partnerships have secured Bayer's rights to acoramidis in Europe and AstraZeneca's rights in Japan, while BridgeBio focuses on the ...

Other pharmaceutical players such as Roche, Amgen, Pfizer, AstraZeneca and Boehringer also have obesity drugs in the pipeline ...

This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 billion in 2024 and is expected to exhibit a CAGR of 7.6% by 2031 BURLINGAME, CA, UNITED STATES, November 12, 2024 ...

AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...

Financially, the company reported $17.1 million in revenues for the quarter, marking a significant improvement from no revenues in the previous year, largely due to milestone payments from Gilead and ...

Amgen stock tumbled late Tuesday on a report that its high-profile weight-loss shot, MariTide, could be linked to bone ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...